Our study offers new insights into the molecular mechanisms of TFE3‐RCC, highlighting the pivotal role of the PRCC‐TFE3/HIF1α/SREBP1 axis in tumor development and progression. This evidence concerns the gene HIF1A and renal cell carcinoma.